164 related articles for article (PubMed ID: 21455297)
1. Transduction and oncolytic profile of a potent replication-competent adenovirus 11p vector (RCAd11pGFP) in colon carcinoma cells.
Silver J; Mei YF
PLoS One; 2011 Mar; 6(3):e17532. PubMed ID: 21455297
[TBL] [Abstract][Full Text] [Related]
2. Replication-competent Ad11p vector (RCAd11p) efficiently transduces and replicates in hormone-refractory metastatic prostate cancer cells.
Sandberg L; Papareddy P; Silver J; Bergh A; Mei YF
Hum Gene Ther; 2009 Apr; 20(4):361-73. PubMed ID: 19199789
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of biodistribution of a fiber-chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice.
Ganesh S; Gonzalez-Edick M; Gibbons D; Waugh J; Van Roey M; Jooss K
Hum Gene Ther; 2009 Oct; 20(10):1201-13. PubMed ID: 19572803
[TBL] [Abstract][Full Text] [Related]
4. Replication-competent human adenovirus 11p vectors can propagate in Vero cells.
Gokumakulapalle M; Mei YF
Virology; 2016 Aug; 495():42-51. PubMed ID: 27176913
[TBL] [Abstract][Full Text] [Related]
5. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
6. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
[TBL] [Abstract][Full Text] [Related]
7. Targeting of adenovirus vectors to tumor cells does not enable efficient transduction of breast cancer metastases.
Shayakhmetov DM; Li ZY; Ni S; Lieber A
Cancer Res; 2002 Feb; 62(4):1063-8. PubMed ID: 11861383
[TBL] [Abstract][Full Text] [Related]
8. Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells.
Ulasov IV; Rivera AA; Han Y; Curiel DT; Zhu ZB; Lesniak MS
J Neurosurg; 2007 Sep; 107(3):617-27. PubMed ID: 17886563
[TBL] [Abstract][Full Text] [Related]
9. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.
Wildner O; Hoffmann D; Jogler C; Uberla K
Cancer Gene Ther; 2003 Oct; 10(10):791-802. PubMed ID: 14502232
[TBL] [Abstract][Full Text] [Related]
10. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
Hoffmann D; Meyer B; Wildner O
J Gene Med; 2007 Sep; 9(9):764-78. PubMed ID: 17640083
[TBL] [Abstract][Full Text] [Related]
11. Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1.
Dias JD; Liikanen I; Guse K; Foloppe J; Sloniecka M; Diaconu I; Rantanen V; Eriksson M; Hakkarainen T; Lusky M; Erbs P; Escutenaire S; Kanerva A; Pesonen S; Cerullo V; Hemminki A
Clin Cancer Res; 2010 May; 16(9):2540-9. PubMed ID: 20388844
[TBL] [Abstract][Full Text] [Related]
12. Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses.
Wildner O; Morris JC
J Gene Med; 2000; 2(5):353-60. PubMed ID: 11045429
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma.
Chen W; Wu Y; Liu W; Wang G; Wang X; Yang Y; Chen W; Tai Y; Lu M; Qian Q; Zhang Q; Chen G
Cancer Lett; 2011 Aug; 307(1):93-103. PubMed ID: 21504839
[TBL] [Abstract][Full Text] [Related]
14. Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus.
Doronin K; Shashkova EV; May SM; Hofherr SE; Barry MA
Hum Gene Ther; 2009 Sep; 20(9):975-88. PubMed ID: 19469693
[TBL] [Abstract][Full Text] [Related]
15. A simple detection system for adenovirus receptor expression using a telomerase-specific replication-competent adenovirus.
Sasaki T; Tazawa H; Hasei J; Osaki S; Kunisada T; Yoshida A; Hashimoto Y; Yano S; Yoshida R; Kagawa S; Uno F; Urata Y; Ozaki T; Fujiwara T
Gene Ther; 2013 Jan; 20(1):112-8. PubMed ID: 22241176
[TBL] [Abstract][Full Text] [Related]
16. 5/35 fiber-modified conditionally replicative adenovirus armed with p53 shows increased tumor-suppressing capacity to breast cancer cells.
He X; Liu J; Yang C; Su C; Zhou C; Zhang Q; Li L; Wu H; Liu X; Wu M; Qian Q
Hum Gene Ther; 2011 Mar; 22(3):283-92. PubMed ID: 20846024
[TBL] [Abstract][Full Text] [Related]
17. Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication.
Kawakami Y; Li H; Lam JT; Krasnykh V; Curiel DT; Blackwell JL
Cancer Res; 2003 Mar; 63(6):1262-9. PubMed ID: 12649186
[TBL] [Abstract][Full Text] [Related]
18. Replication-competent adenoviruses with the type 35-derived fiber-knob region achieve reactive oxygen species-dependent cytotoxicity and produce greater toxicity than those with the type 5-derived region in pancreatic carcinoma.
Yamauchi S; Kawamura K; Okamoto S; Morinaga T; Jiang Y; Shingyoji M; Sekine I; Kubo S; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
Apoptosis; 2015 Dec; 20(12):1587-98. PubMed ID: 26373551
[TBL] [Abstract][Full Text] [Related]
19. Systemic delivery of a novel liver-detargeted oncolytic adenovirus causes reduced liver toxicity but maintains the antitumor response in a breast cancer bone metastasis model.
Zhang Z; Krimmel J; Zhang Z; Hu Z; Seth P
Hum Gene Ther; 2011 Sep; 22(9):1137-42. PubMed ID: 21480822
[TBL] [Abstract][Full Text] [Related]
20. Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors.
Dalba C; Klatzmann D; Logg CR; Kasahara N
Curr Gene Ther; 2005 Dec; 5(6):655-67. PubMed ID: 16457654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
